News

Measuring blood levels of a protein called neurofilament light chain (NfL) may help identify nerve damage in people with hereditary transthyretin amyloidosis with…

DelveInsight's "Cardiac Amyloidosis Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Cardiac Amyloidosis,…

ROLE SUMMARYThe Medical Engagement, Strategy & Insights Director provides senior scientific and medical expertise in Transthyretin Amyloid Cardiomyopathy (ATTR-…

Scientific Frontline: Extended "At a Glance" Summary: Hereditary ATTR Amyloidosis and Redox ImbalanceThe Core Concept: Hereditary ATTR amyloidosis is a progressive…

AbstractBackgroundVal142Ile hereditary transthyretin amyloidosis (hATTR) is an underrecognized cause of heart failure with preserved ejection fraction (HFpEF) in…

AbstractHereditary transthyretin amyloidosis (ATTRv) is a progressive, life-threatening disease caused by mutations in the TTR gene. It is characterized by marked…

AbstractTransthyretin cardiac amyloidosis (ATTR-CM) is an increasingly recognized infiltrative cardiomyopathy characterized by progressive myocardial amyloid…

Immunoglobulin light chain (AL) amyloidosis and POEMS syndrome are plasma cell proliferative disorders involving multiple organs and tissues, often presenting with…

ATTR-CM is progressive, underdiagnosed, and hits our community hardest. Here's what you need to know.Morgan Freeman has played God, not once, but twice on screen,…

AbstractLight chain (AL) amyloidosis is a systemic disorder caused by plasma cell dyscrasia, with cardiac involvement being the primary determinant of prognosis.…